RT Journal Article SR Electronic T1 Therapies for dactylitis in psoriatic arthritis. A systematic review. JF The Journal of Rheumatology JO J Rheumatol FD The Journal of Rheumatology SP 1439 OP 1441 VO 33 IS 7 A1 Philip S Helliwell YR 2006 UL http://www.jrheum.org/content/33/7/1439.abstract AB Dactylitis is a hallmark clinical feature of psoriatic arthritis (PsA). Acute dactylitis appears to be a severity marker for PsA and psoriasis. Traditionally, clinicians have used nonsteroidal antiinflammatory rheumatic drugs and local corticosteroid injections to treat dactylitis, although conventional disease modifying antirheumatic drugs also are recommended. In this systematic review, the limited data on treatments for dactylitis in PsA highlight the need for a valid, reliable, and responsive clinical outcome measure. Infliximab is the only drug to demonstrate significant improvement of dactylitis during a clinical study.